EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Age-specific impact of different immunosuppressive regimens on kidney transplant outcomes: clinical evidence from the scientific registry of transplant recipients

Lina Maria Serna-Higuita, Sarah Kalmbach, Anja Schork, Nils Heyne, Sandra Beer-Hammer, Silvio Nadalin, Peter Martus, Alfred Königsrainer, Moritz Schmelzle, Markus Quante

Frontiers in Nephrology · 14.08.2026 · 6

DOI: 10.3389/fneph.2026.1886887 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Nephrology, online erschienen am 14.08.2026. Verfasst von Lina Maria Serna-Higuita und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Epidemiology and Applied Biostatistics, University Hospital Tübingen, Tübingen, Germany. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although older kidney transplant recipients have a higher risk of side effects leading to infection and malignancies, the impact of different immunosuppressive regimens on clinical outcomes in this group remains unclear.

Methods

Retrospective cohort study analyzing data from the Scientific Registry of Transplant Recipients database. Kidney transplant recipients were categorized according to age categories (18–64 and >65 years) and immunosuppressive maintenance regimens: tacrolimus/mycophenolate mofetil (Tac-MMF), Tac/mTOR-inhibitor (Tac-mTORi), cyclosporin/MMF (CsA-MMF) and mTORi-MMF. The primary endpoint was overall survival.

Results

Among the 112, 952 patients analyzed, overall survival rates at 2-, 3- and 5-years post-transplant were 95.6%, 93.7% and 87.6% respectively. No significant differences in the risk of mortality, graft loss or acute rejection were observed between patients treated with Tac-mTORi and those receiving Tac-MMF. Furthermore, no significant interactions were found between the maintenance immunosuppressive regimens and recipient age groups. Regarding kidney function, younger patients on the Tac-mTORi compared with Tac-MMF regimen exhibited a lower mean eGFR throughout the follow-up period compared to those on Tac-MMF. In contrast to this younger cohort, older patients treated with Tac-mTORi did not experience a significant additional decline in renal function.

Conclusion

In this study, Tac-mTORi and Tac-MMF showed comparable results regarding patient survival, graft survival and rejection rates. Because older patients remain at higher risk for drug-related side effects, including infections, metabolic disorders and malignancies, these results highlight the critical need for individually immunosuppressive regimens in older transplant recipients and warrant further prospective validation.

Schlagwörter

Stichwörter der Autor:innen

agegraft lossimmunosuppressive regimenskidney transplantationsurvival

Autor:innen und Institutionen

  • Institute of Clinical Epidemiology and Applied Biostatistics, University Hospital Tübingen, Tübingen, Germany.
  • Department of General, Visceral and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany.
  • Department of Internal Medicine IV, Division of Diabetology, Endocrinology Nephrology, University Hospital Tübingen, Tübingen, Germany.
  • Department of Pharmacology, Experimental Therapy & Toxicology and Interfaculty Center of Pharmacogenomics & Drug Research (IZePhA), University Hospitals and Clinics, Eberhard Karls University Tübingen, Tübingen, Germany.
  • German Center for Diabetes Research (DZD), Tübingen, Germany.
  • Department of General, Visceral and Transplant Surgery, Hannover Medical School, Hannover, Germany.

Zitieren

APA

Serna-Higuita, L. M., Kalmbach, S., Schork, A., Heyne, N., Beer-Hammer, S., Nadalin, S., Martus, P., Königsrainer, A., Schmelzle, M., & Quante, M. (2026). Age-specific impact of different immunosuppressive regimens on kidney transplant outcomes: clinical evidence from the scientific registry of transplant recipients. Frontiers in Nephrology, 6. https://doi.org/10.3389/fneph.2026.1886887

Vancouver

Serna-Higuita LM, Kalmbach S, Schork A, Heyne N, Beer-Hammer S, Nadalin S, et al. Age-specific impact of different immunosuppressive regimens on kidney transplant outcomes: clinical evidence from the scientific registry of transplant recipients. Frontiers in Nephrology. 2026;6. doi:10.3389/fneph.2026.1886887

BibTeX
@article{SernaHiguita2026,
  author = {Serna-Higuita, Lina Maria and Kalmbach, Sarah and Schork, Anja and Heyne, Nils and Beer-Hammer, Sandra and Nadalin, Silvio and Martus, Peter and Königsrainer, Alfred and Schmelzle, Moritz and Quante, Markus},
  title = {Age-specific impact of different immunosuppressive regimens on kidney transplant outcomes: clinical evidence from the scientific registry of transplant recipients},
  journal = {Frontiers in Nephrology},
  year = {2026},
  volume = {6},
  doi = {10.3389/fneph.2026.1886887}
}
Kostenlos starten →